Announced Tue, 27 Oct, 2026 · 10:49 IST

Chintan Makhecha allotted warrants equal to 5.66% stake

Creeping Acquisition Near ThresholdOwnership Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹42.90
prior close
—
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.7%-1.7% vs market
Pharmaceuticals peers, median of 173sector+2.0%-2.0% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 2.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0+1.7-1.7+2.0-2.0
Next day
+10.0pendingpending+2.6+7.3
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Chintan Vijay Makhecha, a non-promoter, was allotted 800,000 convertible warrants through a preferential issue. They represent a 5.66% voting stake after full conversion, crossing the 5% disclosure threshold. The company has 7,545,056 equity shares now and 14,145,056 shares assuming conversion of all outstanding convertibles.

Likely market impact

Makhecha could gain a 5.66% vote. Fully diluted capital is 14.15 million versus 7.55 million issued, implying dilution if all convertibles convert.